Jefferies Financial Group Inc. Acquires 10,213 Shares of Corteva, Inc. $CTVA

Jefferies Financial Group Inc. boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 96.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,779 shares of the company’s stock after buying an additional 10,213 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Corteva were worth $1,405,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CTVA. Activest Wealth Management boosted its stake in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. True Wealth Design LLC grew its holdings in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the last quarter. Total Investment Management Inc. acquired a new position in Corteva during the 2nd quarter worth approximately $27,000. Twin Peaks Wealth Advisors LLC acquired a new position in Corteva during the 2nd quarter worth approximately $29,000. Finally, Redmont Wealth Advisors LLC bought a new position in Corteva in the 3rd quarter valued at approximately $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.14% of the company’s stock.

Corteva Trading Up 3.1%

CTVA opened at $78.65 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $80.90. The company’s 50 day moving average price is $73.63 and its two-hundred day moving average price is $69.13. The firm has a market capitalization of $52.89 billion, a price-to-earnings ratio of 49.78, a PEG ratio of 2.61 and a beta of 0.72.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the firm earned $0.32 earnings per share. The company’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Bank of America boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Oppenheimer set a $86.00 price target on Corteva in a research note on Thursday, February 5th. UBS Group downgraded Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Finally, Argus raised Corteva to a “strong-buy” rating in a report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.